Keith W. Pfeil has served as President and Chief Executive Officer of Globus Medical, Inc. since July 2025 and has been a member of the Company's Board of Directors since that time. He previously served as Chief Operating Officer and Chief Financial Officer beginning in February 2024 and as Chief Financial Officer from August 2019 to February 2024.
During his tenure with the Company, Mr. Pfeil has overseen a broad portfolio of functions, including finance, operations, information technology, quality, strategy, investor relations, tax, pricing, internal audit and business development. He played a leadership role in the Company's strategic combination with NuVasive, Inc. and the subsequent integration of the two organizations, serving on the Executive Steering Committee for the integration.
Prior to joining Globus Medical, Mr. Pfeil spent more than 15 years at CSS Industries, Inc., a publicly traded consumer products company, where he held roles of increasing responsibility across audit, controllership, financial planning and analysis, investor relations, treasury and business development, culminating in his service as Executive Vice President and Chief Financial Officer. Earlier in his career, he held positions within the assurance and transaction advisory practices of Ernst & Young LLP, KPMG LLP and Arthur Andersen LLP.
Mr. Pfeil holds a Bachelor of Science degree in Accounting from Elizabethtown College and an M.B.A. from Saint Joseph's University.